Crossmark

Immunogenicity of fractional and standard dose COVID-19 vaccine boosters among healthy adults in Indonesia: twenty four month follow-up from a randomised controlled trial

Crossref DOI link: https://doi.org/10.1038/s41467-025-63598-6

Published Online: 2025-09-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hart, John D. https://orcid.org/0000-0002-9637-7974
Fadlyana, Eddy

Mazarakis, Nadia https://orcid.org/0000-0001-7681-2775
Putri, Nina Dwi

Watts, Emma

Moore, Kerryn A. https://orcid.org/0000-0002-8333-8271
Neal, Eleanor F. G.

Setiabudi, Djatnika

Putra, Muhammad Gilang Dwi https://orcid.org/0000-0002-6199-2125
Nguyen, Cattram https://orcid.org/0000-0002-0599-8645
Zhafira, Aqila Sakina

Wicaksana, Pratama

Sinto, Robert

Oktavia, Dwi

Fajarani, Rini

Indrati, Agnes Rengga https://orcid.org/0000-0003-3923-9767
Murad, Chrysanti

Hartantri, Yovita https://orcid.org/0000-0002-1267-7815
Suryadinata, Hendarsyah

Sofiatin, Yulia

Rusmil, Kusnandi

Satari, Hindra I.

Hadinegoro, Sri Rezeki.

Kartasasmita, Cissy B.

Sundoro, Julitasari

Licciardi, Paul V. https://orcid.org/0000-0001-6086-6285
von Mollendorf, Claire

Mulholland, Edward K.
Funding

Funding for this research was provided by:

Coalition for Epidemic Preparedness Innovations
License Information

Text and Data Mining valid from 2025-09-29

Version of Record valid from 2025-09-29
More Information

Article History

Received: 6 May 2025

Accepted: 21 August 2025

First Online: 29 September 2025

Competing interests

: C.B.K., S.R.H., and J.S. are members of the Indonesian Technical Advisory Group on Immunisation. All other authors declare no competing interests.

Document is current

Any future updates will be listed below